Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways-Reference-Cited by-同舟云学术

Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways

Published:2023-01 Issue: Volume:370 Page:110329
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Hsu Chia-Hung,Weng Pei‐Wei,Chen Ming-Yao,Yeh Chi-Tai,Setiawan Syahru Agung^ORCID,Yadav Vijesh Kumar,Wu Alexander T.H.,Tzeng David T.W.,Gong Jian-Xian,Yang Zhen,Tzeng Yew-Min^ORCID

Funder

Taipei Medical University Shuang Ho Hospital Ministry of Health and Welfare

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference44 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

2. Emerging agents and regimens for hepatocellular carcinoma;Zhu;J. Hematol. Oncol.,2019

3. Targeted therapy for hepatocellular carcinoma: challenges and opportunities;Chen;Cancer Lett.,2019

4. Antrocin sensitizes prostate cancer cells to radiotherapy through inhibiting PI3K/AKT and MAPK signaling pathways;Chen;Cancers,2019

5. Identification of antrocin from Antrodia camphorata as a selective and novel class of small molecule inhibitor of Akt/mTOR signaling in metastatic breast cancer MDA-MB-231 cells;Rao;Chem. Res. Toxicol.,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review;Molecular Diversity;2024-01-30